Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

93 results about "Cleistanone" patented technology

Aryl naphthalene's lignans are extracted by pet. ether from Cleistanthus collinus. The bark, leaves, heartwood, fruits and other parts of this plant are rich in lignans cleistanone along with ...

Application of cleistanone diethylamine derivative in preparing drug for resisting acute gout

The invention relates to the field of organic synthesis and pharmaceutical chemistry, and specifically relates to a cleistanone derivative, a preparation method and an application of the cleistanone derivative in preparing a drug for resisting acute gout. The invention synthesizes a novel cleistanone derivative, and discloses a preparation method thereof. Pharmacology experiments show that the cleistanone derivative provided by the invention has the effects of resisting the acute gout and has the value of developing the drug for resisting the acute gout.
Owner:王英

Application of O-(tetrahydropyrrole) ethyl derivative of cleistanone in preparation of medicines for preventing or treating pancreatic fibrosis

ActiveCN104147019AGood anti-fibrosis effect of pancreasOrganic active ingredientsDigestive systemCleistanoneMedicinal chemistry
The invention relates to the fields of organic synthesis and medicinal chemistry and in particular relates to an O-(tetrahydropyrrole) ethyl derivatives of cleistanone, a preparation method of the O-(tetrahydropyrrole) ethyl derivative of cleistanone as well as application of the O-(tetrahydropyrrole) ethyl derivative of cleistanone in preparation of medicines for preventing or treating pancreatic fibrosis. A novel O-(tetrahydropyrrole) ethyl derivative of the cleistanone is synthesized, and the invention also discloses a preparation method of the O-(tetrahydropyrrole) ethyl derivative. The pharmacology experiment proves that the O-(tetrahydropyrrole) ethyl derivative of the cleistanone has an effect of preventing or treating the pancreatic fibrosis and has the value of developing the medicine for preventing or treating the pancreatic fibrosis.
Owner:JASAN BIO MEDICINE JIAXING CO LTD

Application of O-(piperazinyl) ethyl derivative of cleistanone to preparation of medicine for resisting erythrocyte hypoplastic anemia

The invention relates to the fields of organic synthesis and pharmaceutical chemistry, in particular to O-(piperazinyl) ethyl derivative of cleistanone, and a preparation method and the application of the O-(piperazinyl) ethyl derivative to the preparation of medicine for resisting erythrocyte hypoplastic anemia. The invention compounds new O-(piperazinyl) ethyl derivative, and discloses a preparation method thereof. Pharmacology experiments show that the O-(piperazinyl) ethyl derivative has the effect of resisting erythrocyte hypoplastic anemia, and has the value of developing medicine for resisting erythrocyte hypoplastic anemia.
Owner:冬青南京生物科技有限公司

Application of 0-(1H-tetrazole)ethyl derivative of Cleistanone to preparation of anti-heart-failure medicine

InactiveCN104814968AGood anti-heart failure effectOrganic active ingredientsSteroidsCleistanone1H-tetrazole
The invention relates to the field of organic synthesis and medicinal chemistry, in particular to a Cleistanone derivative, a preparation method and application of the Cleistanone derivative to preparation of an anti-heart-failure medicine. A novel Cleistanone derivative is synthesized, and a preparation method of the novel Cleistanone derivative is disclosed. Pharmacology experiments show that the Cleistanone derivative has an anti-heart-failure function and has the value of developing an anti-heart-failure medicine.
Owner:NANJING GUANGKANGXIE BIOLOGICAL MEDICAL TECH

Application of Cleistanone diethylamine derivative in preparation of drugs for resisting anemia caused by low red blood cell level

The invention relates to the field of organic synthesis and pharmaceutical chemistry and particularly relates to a Cleistanone derivative, a preparation method thereof and use thereof in the preparation of drugs for resisting anemia caused by low red blood cell level. According to the invention, a novel Cleistanone derivative is synthesized, and a preparation method of the novel Cleistanone derivative is disclosed. Pharmacological experiments indicate that the Cleistanone derivative disclosed by the invention has an effect of resisting anemia caused by low red blood cell level and has a value in the development of the drugs for resisting anemia caused by low red blood cell level.
Owner:湖北团黄贡茶有限公司

Application of O-(tetrahydropyrrole) ethyl derivative of cleistanthus sumatranus ketone in preparation of medicine for treating or preventing renal fibrosis

InactiveCN104188978AGood anti-renal fibrosis effectOrganic active ingredientsUrinary disorderCleistanoneKetone
The invention relates to the fields of organic synthesis and medicinal chemistry, and particularly relates to an O-(tetrahydropyrrole) ethyl derivative of cleistanthus sumatranus ketone Cleistanone, a preparation method and an application of the O-(tetrahydropyrrole) ethyl derivative in preparation of a medicine for preventing or treating renal fibrosis. The invention synthesizes a novel O-(tetrahydropyrrole) ethyl derivative of the cleistanthus sumatranus ketone Cleistanone, and discloses a preparation method of the O-(tetrahydropyrrole) ethyl derivative. A pharmacology experiment shows that the O-(tetrahydropyrrole) ethyl derivative of the cleistanthus sumatranus ketone Cleistanone has the effect of preventing or treating the renal fibrosis, and has the value of developing the medicine for preventing or treating the renal fibrosis.
Owner:于钦密

Application of cleistanone O-(benzimidazolyl) ethyl derivative in preparation of drugs for treating acute gout

The invention relates to the fields of organic synthesis and pharmaceutical chemistry, and specifically relates to a cleistanone derivative, a preparation method thereof, and an application of the cleistanone derivative in the preparation of drugs for treating acute gout. A novel cleistanone derivative is synthesized, and a preparation method thereof is disclosed. The pharmacological experiments show that the cleistanone derivative has an effect on resisting acute gout and can be used to develop drugs for treating acute gout.
Owner:NANJING GUANGKANGXIE BIOLOGICAL MEDICAL TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products